Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Low booster uptake in cancer patients despite health benefits.
Journal: medRxiv : the preprint server for health sciences
Published: November 14, 2023
Low booster uptake in cancer patients despite health benefits.
Journal: iScience
Published: October 30, 2023
Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study.
Journal: Oncotarget
Published: November 07, 2022
Safety and Efficacy Outcomes From a Single-Center Study of Image-Guided Percutaneous Microwave Ablation for Primary and Metastatic Lung Malignancy.
Journal: JTO clinical and research reports
Published: September 07, 2022
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer (MYSTIC).
Journal: Clinical lung cancer
Published: December 21, 2020
Three Primary Tumors Including EGFR-mutated Non-Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni Syndrome.
Journal: Clinical lung cancer
Published: April 27, 2020
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: April 10, 2020
Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 07, 2019
EGFR Genotyping of Matched Urine, Plasma, and Tumor Tissue in Patients With Non-Small-Cell Lung Cancer Treated With Rociletinib, an EGFR Tyrosine Kinase Inhibitor.
Journal: JCO precision oncology
Published: November 01, 2018
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 16, 2018
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 17, 2018
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
Journal: Clinical lung cancer
Published: January 03, 2018
Last Updated: 09/26/2026